Keerthi Gogineni

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Randomized Controlled Trial

Positive Breast Cancer

Preterm Infants

Top Venues

JCO oncology practice

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Carmen J Calfa, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Eugene R Ahn, Monika L Burness, Keerthi Gogineni, Nitin Rohatgi, Tareq Al Baghdadi, Alison Conlin, Anu Gaba, Omid Hamid, Jairam Krishnamurthy, Naga Jyothi Gavini, Philip J Gold, Jordi Rodon Ahnert, J Scott Roberts, Ramya Thota, Gina N Grantham, Dominique C Hinshaw, Abigail Gregory, Susan Halabi, Richard L Schilsky
Sunitinib in Patients With Breast Cancer With FGFR1 or FGFR2 Amplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study. JCO precision oncology 8 (2024)
Ilana Graetz, Samuel Hernandez, Sara Arshad, Kristina Byers, Jane Meisel, Gelareh Sadigh, Elizabeth A Sakach, Keerthi Gogineni, Mylin A Torres
Leveraging Mobile Health to Improve Capecitabine Adherence Among Women With Breast Cancer: A Pilot Randomized Controlled Trial. JCO oncology practice (2024)
Ilana Graetz, Samuel Hernandez, Sara Arshad, Kristina Byers, Jane Meisel, Gelareh Sadigh, Elizabeth A Sakach, Keerthi Gogineni, Mylin A Torres
Leveraging Mobile Health to Improve Capecitabine Adherence Among Women With Breast Cancer: A Pilot Randomized Controlled Trial. JCO oncology practice (2024)
Ilana Graetz, Samuel Hernandez, Sara Arshad, Kristina Byers, Jane Meisel, Gelareh Sadigh, Elizabeth A Sakach, Keerthi Gogineni, Mylin A Torres
Leveraging Mobile Health to Improve Capecitabine Adherence Among Women With Breast Cancer: A Pilot Randomized Controlled Trial. JCO oncology practice (2024)
Keerthi Gogineni, Kevin Kalinsky
Individualizing Adjuvant Therapy in Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Node-Positive Breast Cancer. JCO oncology practice 18 (4) (2022)